The cost of prescription drugs has been increasing over the past years across the United States. Its impact steadily affects all healthcare industry sectors, especially health insurance policies. Employers are finding it difficult to get the value of what they insure, therefore passing the cost of drugs to employees.
In a recent study by AHIP, over…
Shots:
The EC has approved to 5 Biologics and 3 New Chemical Entities in August 2024, leading to treatments for patients and advances in the healthcare industry
The major highlighted drugs were Johnson & Johnson’s Balversa to treat Metastatic Urothelial Carcinoma (mUC) and Takeda’s Adzynma for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
PharmaShots has compiled a list…
Shots:
The EMA granted Positive Opinion to 2 Biologics and 5 New Chemical Entities in July 2024, leading to treatments for patients and advances in the healthcare industry
The major highlighted drugs were Johnson & Johnson’s Yuvanci to treat Pulmonary Arterial Hypertension (PAH) and Astellas’ Vyloy + CT for Gastric & Gastroesophageal Junction Cancer
PharmaShots has compiled a list…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of July 2024
The US FDA approved a total of 2 new drugs including 1 new molecular entity and 1 biologic leading to the treatments for patients and advances in the healthcare industry
The major highlighted drug was Eli Lilly’s Kisunla for…
Shots:
The EMA granted Positive Opinion to 4 Biologics and 3 New Chemical Entities in June 2024, leading to treatments for patients and advances in the healthcare industry
The major highlighted drugs were Merck’s Winrevair to treat Pulmonary Arterial Hypertension (PAH) and Roche’s PiaSky for Paroxysmal Nocturnal Haemoglobinuria (PNH)
PharmaShots has compiled a list of 5 drugs that…
Shots:
Small cell lung cancer (SCLC) aka Oat cell carcinoma is a rare & fast-growing lung cancer and ~15% of bronchogenic carcinomas are SCLC
In this reprise of our Disease of the Month report, we bring an illuminating account of SCLC with a dive analysis of epidemiology, market size, disease management, available therapies, patient advocacy…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of June 2024
The US FDA approved a total of 5 new drugs including 4 new molecular entities and 1 biologic leading to the treatments for patients and advances in the healthcare industry
The major highlighted drug was Ipsen’s Iqirvo for the treatment…
Shots:
New-age technologies are transforming the healthcare industry continuously. By leveraging digital health platforms, AI-powered apps, and other innovative solutions, there is a significant enhancement in diagnosis, treatment, and prevention
With a global market revenue of $180.2B in 2023, the market is projected to reach $549.7B by 2028, registering a CAGR of 25 percent. This…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of May 2024
The US FDA approved a total of 3 new drugs including 2 new molecular entities and 1 biologic leading to treatments for patients and advances in the healthcare industry
The major highlighted drug was Amgen’s Imdelltra for the treatment…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of April 2024
The US FDA approved a total of 12 new drugs including 11 new molecular entities and 1 biologic leading to the treatments for patients and advances in the healthcare industry
The major highlighted drug was X4 Pharmaceuticals’ Xolremdi for…

